Reactive oxygen species in normal and tumor stem cells

Advances in Cancer Research

Volumn 122, Issue , 2014, Pages 1-67

  Zhou, Daohong ^a   Shao, Lijian ^a   Spitz, Douglas R ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Adult stem cells; Apoptosis; Differentiation; Embryonic stem cells; Hematopoietic stem cells; Hypoxia; Ionizing radiation; Reactive oxygen species; Senescence; Tumor stem cells

Indexed keywords

ANTIOXIDANT; ARF PROTEIN; ATM PROTEIN; BMI1 PROTEIN; CATALASE; CYTOCHROME P450; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN LYSINE 6 OXIDASE; PROTEIN P16; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; TRANSCRIPTION FACTOR FOXO;

ADULT STEM CELL; AEROBIC METABOLISM; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; CELL METABOLISM; CELL SURVIVAL; CHRONIC INFLAMMATION; DISEASE COURSE; DNA DAMAGE; EMBRYONIC STEM CELL; ENZYME METABOLISM; GENETIC POLYMORPHISM; GENOMIC INSTABILITY; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SPACE; LEUKEMIA CELL; LIFESPAN; LIPID OXIDATION; LIPID PEROXIDATION; MACROMOLECULE; MITOCHONDRION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REGULATORY MECHANISM; RESPIRATORY CHAIN; STEADY STATE; STEM CELL; TOTIPOTENT STEM CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; ANOXIA; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; HOMEOSTASIS; IONIZING RADIATION; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY;

ANIMALS; ANOXIA; ANTIOXIDANTS; APOPTOSIS; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC STEM CELLS; HOMEOSTASIS; HUMANS; MICE; MITOCHONDRIA; NEOPLASMS; NEOPLASTIC STEM CELLS; RADIATION, IONIZING; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 84902951381     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420117-0.00001-3     Document Type: Chapter

References (370)

1. Abbas H.A., Maccio D.R., Coskun S., Jackson J.G., Hazen A.L., Sills T.M., et al. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell 2010, 7:606-617.
2. 2 mediate glucose deprivation-induced stress in human cancer cells. Journal of Biological Chemistry 2005, 280:4254-4263.
3. Ahmed K.M., Li J.J. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radical Biology & Medicine 2008, 44:1-13.
4. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3983-3988.
5. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 2003, 102:517-520.
6. Anderson K., Lutz C., van Delft F.W., Bateman C.M., Guo Y., Colman S.M., et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011, 469:356-361.
7. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002, 109:39-45.
8. Antonenkov V.D., Grunau S., Ohlmeier S., Hiltunen J.K. Peroxisomes are oxidative organelles. Antioxidants & Redox Signaling 2010, 13:525-537.
9. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118:149-161.
10. Archer V.E. Carcinogenicity of fibers and films: A theory. Medical Hypotheses 1979, 5:1257-1262.
11. Arner E.S., Holmgren A. The thioredoxin system in cancer. Seminars in Cancer Biology 2006, 16:420-426.
12. Ateghang B., Wartenberg M., Gassmann M., Sauer H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1alpha and intracellular reactive oxygen species. Journal of Cell Science 2006, 119:1043-1052.
13. Aykin-Burns N., Ahmad I.M., Zhu Y., Oberley L.W., Spitz D.R. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochemistry Journal 2009, 418:29-37.
14. Aykin-Burns N., Slane B.G., Liu A.T., Owens K.M., O'Malley M.S., Smith B.J., et al. Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species. Radiation Research 2011, 175:150-158.
15. Baccelli I., Trumpp A. The evolving concept of cancer and metastasis stem cells. Journal of Cell Biology 2012, 198:281-293.
16. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
17. Barker H.E., Cox T.R., Erler J.T. The rationale for targeting the LOX family in cancer. Nature Reviews. Cancer 2012, 12:540-552.
18. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
19. Barria E., Mikels A., Haas M. Maintenance and self-renewal of long-term reconstituting hematopoietic stem cells supported by amniotic fluid. Stem Cells and Development 2004, 13:548-562.
20. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:2804-2808.
21. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., et al. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO Journal 2003, 22:4212-4222.
22. Beck B., Blanpain C. Unravelling cancer stem cell potential. Nature Reviews. Cancer 2013, 13:727-738.
23. Becker A.J., Mc C.E., Till J.E. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963, 197:452-454.
24. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. American Journal of Physiology 1996, 271:C1424-C1437.
25. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiological Reviews 2007, 87:245-313.
26. Beddington R.S., Robertson E.J.J. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development 1989, 105:733-737.
27. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
28. Bhatia M., Wang J.C., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:5320-5325.
29. Bize I.B., Oberley L.W., Morris H.P. Superoxide dismutase and superoxide radical in Morris hepatomas. Cancer Research 1980, 40:3686-3693.
30. Blackburn R.V., Spitz D.R., Liu X., Galoforo S.S., Sim J.E., Ridnour L.A., et al. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radical Biology & Medicine 1999, 26:419-430.
31. Bonner M.Y., Arbiser J.L. Targeting NADPH oxidases for the treatment of cancer and inflammation. Cellular and Molecular Life Sciences 2012, 69:2435-2442.
32. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997, 3:730-737.
33. Bosgra S., Mennes W., Seinen W. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis. Toxicology 2005, 206:309-323.
34. Boveris A. Mitochondrial production of superoxide radical and hydrogen peroxide. Advances in Experimental Medicine and Biology 1977, 78:67-82.
35. Boveris A., Cadenas E. Production of superoxide radicals and hydrogen peroxide in mitochondria. Superoxide Dismutase 1982, Vol. 1:15-30. CRC Press, Boca Raton, FL. L.W. Oberley (Ed.).
36. Bradley A., Evans M., Kaufman M.H., Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984, 309:255-256.
37. Broudy V.C. Stem cell factor and hematopoiesis. Blood 1997, 90:1345-1364.
38. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annual Review of Cell and Developmental Biology 1999, 15:269-290.
39. Buettner G.R. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Archives of Biochemistry and Biophysics 1993, 300:535-543.
40. Buettner G.R. Superoxide dismutase in redox biology: The roles of superoxide and hydrogen peroxide. Anti-Cancer Agents in Medicinal Chemistry 2011, 11:341-346.
41. 2 in cells and thereby their biological state. Free Radical Biology & Medicine 2006, 41:1338-1350.
42. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
43. Cam H., Easton J.B., High A., Houghton P.J. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha. Molecular Cell 2010, 40:509-520.
44. Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005, 120:513-522.
45. Campisi J., Kim S.H., Lim C.S., Rubio M. Cellular senescence, cancer and aging: The telomere connection. Experimental Gerontology 2001, 36:1619-1637.
46. Cannizzo E.S., Clement C.C., Sahu R., Follo C., Santambrogio L. Oxidative stress, inflamm-aging and immunosenescence. Journal of Proteomics 2011, 74:2313-2323.
47. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiological Reviews 1979, 59:527-605.
48. Chen C.C., Jeon S.M., Bhaskar P.T., Nogueira V., Sundararajan D., Tonic I., et al. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Developmental Cell 2010, 18:592-604.
49. Chen C., Liu Y., Liu R., Ikenoue T., Guan K.L., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. Journal of Experimental Medicine 2008, 205:2397-2408.
50. Cheng L., Huang Z., Zhou W., Wu Q., Donnola S., Liu J.K., et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 2013, 153:139-152.
51. Chiang E., Dang O., Anderson K., Matsuzawa A., Ichijo H., David M. Cutting edge: Apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide. Journal of Immunology 2006, 176:5720-5724.
52. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
53. Chipuk J.E., Maurer U., Green D.R., Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 2003, 4:371-381.
54. Cho Y.M., Kwon S., Pak Y.K., Seol H.W., Choi Y.M., Park do J., et al. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochemical and Biophysical Research Communications 2006, 348:1472-1478.
55. Chow A., Lucas D., Hidalgo A., Mendez-Ferrer S., Hashimoto D., Scheiermann C., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. Journal of Experimental Medicine 2011, 208:261-271.
56. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:14541-14546.
57. Christophorou M.A., Ringshausen I., Finch A.J., Swigart L.B., Evan G.I. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006, 443:214-217.
58. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. Journal of Immunology 1984, 133:157-165.
59. Clevers H. The cancer stem cell: Premises, promises and challenges. Nature Medicine 2011, 17:313-319.
60. Coso S., Harrison I., Harrison C.B., Vinh A., Sobey C.G., Drummond G.R., et al. NADPH oxidases as regulators of tumor angiogenesis: Current and emerging concepts. Antioxidants & Redox Signaling 2012, 16:1229-1247.
61. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes & Development 2003, 17:3029-3035.
62. Cui Y.F., Zhou P.K., Woolford L.B., Lord B.I., Hendry J.H., Wang D.W. Apoptosis in bone marrow cells of mice with different p53 genotypes after gamma-rays irradiation in vitro. Journal of Environmental Pathology, Toxicology and Oncology 1995, 14:159-163.
63. Cyr A.R., Domann F.E. The redox basis of epigenetic modifications: From mechanisms to functional consequences. Antioxidants & Redox Signaling 2011, 15:551-589.
64. Cyr A.R., Hitchler M.J., Domann F.E. Regulation of SOD2 in cancer by histone modifications and CpG methylation: Closing the loop between redox biology and epigenetics. Antioxidants & Redox Signaling 2013, 18:1946-1955.
65. De Flora S., Ferguson L.R. Overview of mechanisms of cancer chemopreventive agents. Mutation Research 2005, 591:8-15.
66. De Marco F. Oxidative stress and HPV carcinogenesis. Viruses 2013, 5:708-731.
67. Dhar S.K., St Clair D.K. Manganese superoxide dismutase regulation and cancer. Free Radical Biology & Medicine 2012, 52:2209-2222.
68. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
69. Dionisi O., Galeotti T., Terranova T., Azzi A. Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. Biochimica et Biophysica Acta 1975, 403:292-300.
70. Ditch S., Paull T.T. The ATM protein kinase and cellular redox signaling: Beyond the DNA damage response. Trends in Biochemical Sciences 2012, 37:15-22.
71. Domen J., Gandy K.L., Weissman I.L. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 1998, 91:2272-2282.
72. Dong C., Yuan T., Wu Y., Wang Y., Fan T.W., Miriyala S., et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 2013, 23:316-331.
73. Droge W. Free radicals in the physiological control of cell function. Physiological Reviews 2002, 82:47-95.
74. Du W., Adam Z., Rani R., Zhang X., Pang Q. Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxidants & Redox Signaling 2008, 10:1909-1921.
75. Du Y., Zhang H., Lu J., Holmgren A. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. Journal of Biological Chemistry 2012, 287:38210-38219.
76. Du Y., Zhang H., Zhang X., Lu J., Holmgren A. Thioredoxin 1 is inactivated due to oxidation induced by peroxiredoxin under oxidative stress and reactivated by the glutaredoxin system. Journal of Biological Chemistry 2013, 288:32241-32247.
77. Dumitru R., Gama V., Fagan B.M., Bower J.J., Swahari V., Pevny L.H., et al. Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Molecular Cell 2012, 46:573-583.
78. Eijkelenboom A., Burgering B.M. FOXOs: Signalling integrators for homeostasis maintenance. Nature Reviews. Molecular Cell Biology 2013, 14:83-97.
79. Eliasson P., Jonsson J.I. The hematopoietic stem cell niche: Low in oxygen but a nice place to be. Journal of Cellular Physiology 2010, 222:17-22.
80. Eliasson P., Rehn M., Hammar P., Larsson P., Sirenko O., Flippin L.A., et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Experimental Hematology 2010, 38:301-310.e2.
81. Erlacher M., Michalak E.M., Kelly P.N., Labi V., Niederegger H., Coultas L., et al. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005, 106:4131-4138.
82. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
83. Ezashi T., Das P., Roberts R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:4783-4788.
84. Facucho-Oliveira J.M., St John J.C. The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Reviews 2009, 5:140-158.
85. Fath M.A., Ahmad I.M., Smith C.J., Spence J., Spitz D.R. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. Clinical Cancer Research 2011, 17:6206-6217.
86. Filion T.M., Qiao M., Ghule P.N., Mandeville M., van Wijnen A.J., Stein J.L., et al. Survival responses of human embryonic stem cells to DNA damage. Journal of Cellular Physiology 2009, 220:586-592.
87. Finkel T. Radical medicine: Treating ageing to cure disease. Nature Reviews. Molecular Cell Biology 2005, 6:971-976.
88. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
89. Fischer B., Bavister B.D. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. Journal of Reproduction and Fertility 1993, 99:673-679.
90. Fliedner S.M., Kaludercic N., Jiang X.S., Hansikova H., Hajkova Z., Sladkova J., et al. Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: Insights from a mouse cell model applied to human tumor tissue. PLoS One 2012, 7:e40949.
91. Folmes C.D., Nelson T.J., Martinez-Fernandez A., Arrell D.K., Lindor J.Z., Dzeja P.P., et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism 2011, 14:264-271.
92. Forman H.J., Kennedy J.A. Role of superoxide radical in mitochondrial dehydrogenase reactions. Biochemical and Biophysical Research Communications 1974, 60:1044-1050.
93. Forman H.J., Kennedy J. Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid. Journal of Biological Chemistry 1975, 250:4322-4326.
94. Fridovich I. The biology of oxygen radicals. Science 1978, 201:875-880.
95. Fujisaki J., Wu J., Carlson A.L., Silberstein L., Putheti P., Larocca R., et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 2011, 474:216-219.
96. Furth J., Kahn M. The transmission of leukaemia of mice with a single cell. American Journal of Cancer 1937, 31:276-282.
97. Gan B., Sahin E., Jiang S., Sanchez-Aguilera A., Scott K.L., Chin L., et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19384-19389.
98. Geest C.R., Coffer P.J. MAPK signaling pathways in the regulation of hematopoiesis. Journal of Leukocyte Biology 2009, 86:237-250.
99. Gimm O., Armanios M., Dziema H., Neumann H.P., Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Research 2000, 60:6822-6825.
100. Gius D., Spitz D.R. Redox signaling in cancer biology. Antioxidants & Redox Signaling 2006, 8:1249-1252.
101. Goldman D.C., Bailey A.S., Pfaffle D.L., Al Masri A., Christian J.L., Fleming W.H. MP4 regulates the hematopoietic stem cell niche. Blood 2009, 114:4393-4401.
102. Gonda T.A., Tu S., Wang T.C. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009, 8:2005-2013.
103. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine 1996, 183:1797-1806.
104. Goytisolo F.A., Samper E., Martin-Caballero J., Finnon P., Herrera E., Flores J.M., et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. Journal of Experimental Medicine 2000, 192:1625-1636.
105. Greenwood M.J., Lansdorp P.M. Telomeres, telomerase, and hematopoietic stem cell biology. Archives of Medical Research 2003, 34:489-495.
106. Gukovsky I., Li N., Todoric J., Gukovskaya A., Karin M. Inflammation, autophagy, and obesity: Common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology 2013, 144:1199-1209.e4.
107. Guo Y.L., Chakraborty S., Rajan S.S., Wang R., Huang F. Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal. Stem Cells and Development 2010, 19:1321-1331.
108. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
109. Gurdon J.B. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. Journal of Embryology and Experimental Morphology 1962, 10:622-640.
110. Gurdon J.B., Elsdale T.R., Fischberg M. Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 1958, 182:64-65.
111. Guzman M.L., Rossi R.M., Karnischky L., Li X., Peterson D.R., Howard D.S., et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105:4163-4169.
112. Guzman M.L., Rossi R.M., Neelakantan S., Li X., Corbett C.A., Hassane D.C., et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 2007, 110:4427-4435.
113. 2-mediated oxidative stress. Free Radical Biology & Medicine 2010, 48:1024-1033.
114. Halliwell B., Gutteridge J.M. Free radicals in biology and medicine 2007, Oxford University Press Inc., New York, NY. 4th ed.
115. Han M.K., Song E.K., Guo Y., Ou X., Mantel C., Broxmeyer H.E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008, 2:241-251.
116. Haraguchi N., Ishii H., Mimori K., Tanaka F., Ohkuma M., Kim H.M., et al. CD13 is a therapeutic target in human liver cancer stem cells. Journal of Clinical Investigation 2010, 120:3326-3339.
117. Harman D. The free radical theory of aging. Antioxidants & Redox Signaling 2003, 5:557-561.
118. Harman D. Free radical theory of aging: An update: Increasing the functional life span. Annals of the New York Academy of Sciences 2006, 1067:10-21.
119. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nature Medicine 2002, 8:841-849.
120. Haug J.S., He X.C., Grindley J.C., Wunderlich J.P., Gaudenz K., Ross J.T., et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008, 2:367-379.
121. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Experimental Cell Research 1961, 25:585-621.
122. Herault O., Hope K.J., Deneault E., Mayotte N., Chagraoui J., Wilhelm B.T., et al. A role for GPx3 in activity of normal and leukemia stem cells. Journal of Experimental Medicine 2012, 209:895-901.
123. Hirabayashi Y., Matsuda M., Matumura T., Mitsui H., Sasaki H., Tukada T., et al. The p53-deficient hemopoietic stem cells: Their resistance to radiation-apoptosis, but lasted transiently. Leukemia 1997, 11(Suppl 3):489-492.
124. Hitchler M.J., Domann F.E. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radical Biology & Medicine 2009, 47:115-127.
125. Hitchler M.J., Domann F.E. Redox regulation of the epigenetic landscape in cancer: A role for metabolic reprogramming in remodeling the epigenome. Free Radical Biology & Medicine 2012, 53:2178-2187.
126. Hou P., Li Y., Zhang X., Liu C., Guan J., Li H., et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013, 341:651-654.
127. Hoyes K.P., Cai W.B., Potten C.S., Hendry J.H. Effect of bcl-2 deficiency on the radiation response of clonogenic cells in small and large intestine, bone marrow and testis. International Journal of Radiation Biology 2000, 76:1435-1442.
128. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004, 6:587-596.
129. Imaoka S., Osada M., Minamiyama Y., Yukimura T., Toyokuni S., Takemura S., et al. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Letters 2004, 203:117-125.
130. Irwin M.E., Rivera-Del Valle N., Chandra J. Redox control of leukemia: From molecular mechanisms to therapeutic opportunities. Antioxidants & Redox Signaling 2013, 18:1349-1383.
131. Ishii N., Fujii M., Hartman P.S., Tsuda M., Yasuda K., Senoo-Matsuda N., et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 1998, 394:694-697.
132. Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011, 19:387-400.
133. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
134. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature Medicine 2006, 12:446-451.
135. Ito K., Takubo K., Arai F., Satoh H., Matsuoka S., Ohmura M., et al. Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. Journal of Immunology 2007, 178:103-110.
136. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New England Journal of Medicine 2004, 351:657-667.
137. Jang Y.Y., Sharkis S.J. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007, 110:3056-3063.
138. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006, 443:421-426.
139. Ji A.R., Ku S.Y., Cho M.S., Kim Y.Y., Kim Y.J., Oh S.K., et al. Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Experimental & Molecular Medicine 2010, 42:175-186.
140. Ji L., Liu Y.X., Yang C., Yue W., Shi S.S., Bai C.X., et al. Self-renewal and pluripotency is maintained in human embryonic stem cells by co-culture with human fetal liver stromal cells expressing hypoxia inducible factor 1alpha. Journal of Cellular Physiology 2009, 221:54-66.
141. Jin Y., Lu Z., Ding K., Li J., Du X., Chen C., et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: Inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Research 2010, 70:2516-2527.
142. Jorgenson T.C., Zhong W., Oberley T.D. Redox imbalance and biochemical changes in cancer. Cancer Research 2013, 73:6118-6123.
143. Jung P., Sato T., Merlos-Suarez A., Barriga F.M., Iglesias M., Rossell D., et al. Isolation and in vitro expansion of human colonic stem cells. Nature Medicine 2011, 17:1225-1227.
144. Juntilla M.M., Patil V.D., Calamito M., Joshi R.P., Birnbaum M.J., Koretzky G.A. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 2010, 115:4030-4038.
145. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Molecular Cell 2008, 30:393-402.
146. Kaewpila S., Venkataraman S., Buettner G.R., Oberley L.W. Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. Cancer Research 2008, 68:2781-2788.
147. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Science 2009, 100:1382-1388.
148. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Research 2001, 61:1849-1854.
149. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472.
150. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 1972, 26:239-257.
151. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 2010, 141:52-67.
152. Keyse S.M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Reviews 2008, 27:253-261.
153. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
154. Kim H.M., Haraguchi N., Ishii H., Ohkuma M., Okano M., Mimori K., et al. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon. Annals of Surgical Oncology 2012, 19(Suppl 3):S539-S548.
155. Kinder M., Wei C., Shelat S.G., Kundu M., Zhao L., Blair I.A., et al. Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism. Blood 2010, 115:5012-5022.
156. Kirito K., Fox N., Kaushansky K. Thrombopoietin stimulates Hoxb4 expression: An explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 2003, 102:3172-3178.
157. Kobayashi C.I., Suda T. Regulation of reactive oxygen species in stem cells and cancer stem cells. Journal of Cellular Physiology 2012, 27:421-430.
158. Kocabas F., Zheng J., Thet S., Copeland N.G., Jenkins N.A., DeBerardinis R.J., et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 2012, 120:4963-4972.
159. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285:1733-1737.
160. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beilhack G.F., et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annual Review of Immunology 2003, 21:759-806.
161. Koppenol W.H. The Haber-Weiss cycle-70 years later. Redox Report 2001, 6:229-234.
162. Koptyra M., Falinski R., Nowicki M.O., Stoklosa T., Majsterek I., Nieborowska-Skorska M., et al. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006, 108:319-327.
163. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO Journal 2004, 23:1949-1956.
164. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
165. Kunisaki Y., Bruns I., Scheiermann C., Ahmed J., Pinho S., Zhang D., et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013, 502:637-643.
166. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 2001, 81:807-869.
167. Labi V., Erlacher M., Krumschnabel G., Manzl C., Tzankov A., Pinon J., et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes & Development 2010, 24:1602-1607.
168. Lagadinou E.D., Sach A., Callahan K., Rossi R.M., Neering S.J., Minhajuddin M., et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 2013, 12:329-341.
169. Lambeth J.D. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radical Biology & Medicine 2007, 43:332-347.
170. Lansdorp P.M., Sutherland H.J., Eaves C.J. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. Journal of Experimental Medicine 1990, 172:363-366.
171. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
172. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
173. Lee J.M., Bernstein A. p53 Mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:5742-5746.
174. Lee S., Kim S.M., Lee R.T. Thioredoxin and thioredoxin target proteins: From molecular mechanisms to functional significance. Antioxidants & Redox Signaling 2013, 18:1165-1207.
175. Lehninger A.L. Biochemistry 1976, 245-441. Worth Publishers Inc, New York, NY, 467-471, 849-850.
176. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255-260.
177. Lewandowski J.P., Sheehan K.B., Bennett P.E., Boswell R.E. Mago Nashi, Tsunagi/Y14, and Ranshi form a complex that influences oocyte differentiation in Drosophila melanogaster. Developmental Biology 2010, 339:307-319.
178. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., et al. The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Molecular Biology of the Cell 2006, 17:3978-3988.
179. Li H., Wang Y., Pazhanisamy S.K., Shao L., Batinic-Haberle I., Meng A., et al. Mn(III) meso-tetrakis-(N-ethylpyridinium-2-yl) porphyrin mitigates total body irradiation-induced long-term bone marrow suppression. Free Radical Biology & Medicine 2011, 51:30-37.
180. Li D., Wang Y., Wu H., Lu L., Zhang H., Chang J., et al. Mitigation of ionizing radiation-induced bone marrow suppression by p38 inhibition and G-CSF administration. Journal of Radiation Research 2011, 52:712-716.
181. Li Y., Wicha M.S., Schwartz S.J., Sun D. Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. Journal of Nutritional Biochemistry 2011, 22:799-806.
182. Li S., Yan T., Yang J.Q., Oberley T.D., Oberley L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Research 2000, 60:3927-3939.
183. Lipton B.H., Schultz E. Developmental fate of skeletal muscle satellite cells. Science 1979, 205:1292-1294.
184. Liu J., Cao L., Chen J., Song S., Lee I.H., Quijano C., et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 2009, 459:387-392.
185. Liu J., Cao L., Finkel T. Oxidants, metabolism, and stem cell biology. Free Radical Biology & Medicine 2011, 51:2158-2162.
186. Liu J.C., Guan X., Ryan J.A., Rivera A.G., Mock C., Agarwal V., et al. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell 2013, 13:483-491.
187. Lowe S.W., Sherr C.J. Tumor suppression by Ink4a-Arf: Progress and puzzles. Current Opinion in Genetics & Development 2003, 13:77-83.
188. Lu J., Holmgren A. The thioredoxin antioxidant system. Free Radical Biology & Medicine 2014, 66:75-87.
189. Madlambayan G.J., Rogers I., Kirouac D.C., Yamanaka N., Mazurier F., Doedens M., et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Experimental Hematology 2005, 33:1229-1239.
190. Magee J.A., Ikenoue T., Nakada D., Lee J.Y., Guan K.L., Morrison S.J. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Cell Stem Cell 2012, 11:415-428.
191. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. American Journal of Pathology 1995, 146:3-15.
192. Marcotte R., Wang E. Replicative senescence revisited. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2002, 57:B257-B269.
193. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America 1981, 78:7634-7638.
194. Maryanovich M., Oberkovitz G., Niv H., Vorobiyov L., Zaltsman Y., Brenner O., et al. The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nature Cell Biology 2012, 14:535-541.
195. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
196. Matsuzawa A., Ichijo H. Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochimica et Biophysica Acta 2008, 1780:1325-1336.
197. Mauch P., Constine L., Greenberger J., Knospe W., Sullivan J., Liesveld J.L., et al. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology, Biology, Physics 1995, 31:1319-1339.
198. Mauro A. Satellite cell of skeletal muscle fibers. Journal of Biophysical and Biochemical Cytology 1961, 9:493-495.
199. Mazumdar J., Dondeti V., Simon M.C. Hypoxia-inducible factors in stem cells and cancer. Journal of Cellular and Molecular Medicine 2009, 13:4319-4328.
200. McCulloch E.A., Till J.E. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiation Research 1960, 13:115-125.
201. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
202. Menon S.G., Goswami P.C. A redox cycle within the cell cycle: Ring in the old with the new. Oncogene 2007, 26:1101-1109.
203. Mercher T., Cornejo M.G., Sears C., Kindler T., Moore S.A., Maillard I., et al. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 2008, 3:314-326.
204. Meredith M.J., Dodson M.L. Impaired glutathione biosynthesis in cultured human ataxia-telangiectasia cells. Cancer Research 1987, 47:4576-4581.
205. Michalak E.M., Vandenberg C.J., Delbridge A.R., Wu L., Scott C.L., Adams J.M., et al. Apoptosis-promoted tumorigenesis: Gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes & Development 2010, 24:1608-1613.
206. Miyamoto K., Araki K.Y., Naka K., Arai F., Takubo K., Yamazaki S., et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1:101-112.
207. Miyamoto T., Weissman I.L., Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7521-7526.
208. Mohyeldin A., Garzon-Muvdi T., Quinones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010, 7:150-161.
209. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
210. Monfort A., Wutz A. Breathing-in epigenetic change with vitamin C. EMBO Reports 2013, 14:337-346.
211. Murray L., Chen B., Galy A., Chen S., Tushinski R., Uchida N., et al. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. Blood 1995, 85:368-378.
212. Nagano O., Okazaki S., Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013, 32:5191-5198.
213. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annual Review of Immunology 1997, 15:51-69.
214. Nakamura S., Oshima M., Yuan J., Saraya A., Miyagi S., Konuma T., et al. Bmi1 confers resistance to oxidative stress on hematopoietic stem cells. PLoS One 2012, 7:e36209.
215. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
216. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: An immunologist's guide to reactive oxygen species. Nature Reviews. Immunology 2013, 13:349-361.
217. Navas T.A., Mohindru M., Estes M., Ma J.Y., Sokol L., Pahanish P., et al. Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood 2006, 108:4170-4177.
218. Nguyen P., Awwad R.T., Smart D.D., Spitz D.R., Gius D. Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Letters 2006, 236:164-174.
219. Nguyen L.V., Vanner R., Dirks P., Eaves C.J. Cancer stem cells: An evolving concept. Nature Reviews. Cancer 2012, 12:133-143.
220. Nieborowska-Skorska M., Kopinski P.K., Ray R., Hoser G., Ngaba D., Flis S., et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 2012, 119:4253-4263.
221. Nilsson S.K., Johnston H.M., Whitty G.A., Williams B., Webb R.J., Denhardt D.T., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
222. Nordgren M., Fransen M. Peroxisomal metabolism and oxidative stress. Biochimie 2014, 98:56-62.
223. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
224. Notta F., Mullighan C.G., Wang J.C., Poeppl A., Doulatov S., Phillips L.A., et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011, 469:362-367.
225. Nowak J.A., Polak L., Pasolli H.A., Fuchs E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 2008, 3:33-43.
226. Nowicki M.O., Falinski R., Koptyra M., Slupianek A., Stoklosa T., Gloc E., et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004, 104:3746-3753.
227. Oberley L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomedicine and Pharmacotherapy 2005, 59:143-148.
228. Oberley L.W., Bize I.B., Sahu S.K., Leuthauser S.W., Gruber H.E. Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. Journal of the National Cancer Institute 1978, 61:375-379.
229. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: A review. Cancer Research 1979, 39:1141-1149.
230. Oberley L.W., Oberley T.D., Buettner G.R. Cell differentiation, aging and cancer: The possible roles of superoxide and superoxide dismutases. Medical Hypotheses 1980, 6:249-268.
231. Oberley L.W., Oberley T.D., Buettner G.R. Cell division in normal and transformed cells: The possible role of superoxide and hydrogen peroxide. Medical Hypotheses 1981, 7:21-42.
232. Ogasawara M.A., Zhang H. Redox regulation and its emerging roles in stem cells and stem-like cancer cells. Antioxidants & Redox Signaling 2009, 11:1107-1122.
233. Oguro H., Iwama A., Morita Y., Kamijo T., van Lohuizen M., Nakauchi H. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. Journal of Experimental Medicine 2006, 203:2247-2253.
234. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12313-12318.
235. Ohshima H., Tatemichi M., Sawa T. Chemical basis of inflammation-induced carcinogenesis. Archives of Biochemistry and Biophysics 2003, 417:3-11.
236. Omatsu Y., Sugiyama T., Kohara H., Kondoh G., Fujii N., Kohno K., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
237. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
238. Owens K.M., Aykin-Burns N., Dayal D., Coleman M.C., Domann F.E., Spitz D.R. Genomic instability induced by mutant succinate dehydrogenase subunit D (SDHD) is mediated by O2(-) and H2O2. Free Radical Biology & Medicine 2012, 52:160-166.
239. Owusu-Ansah E., Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009, 461:537-541.
240. Pani G., Galeotti T., Chiarugi P. Metastasis: Cancer cell's escape from oxidative stress. Cancer Metastasis Reviews 2010, 29:351-378.
241. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
242. Parmar K., Mauch P., Vergilio J.A., Sackstein R., Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:5431-5436.
243. Patterson K.I., Brummer T., O'Brien P.M., Daly R.J. Dual-specificity phosphatases: Critical regulators with diverse cellular targets. Biochemistry Journal 2009, 418:475-489.
244. Payne S.L., Fogelgren B., Hess A.R., Seftor E.A., Wiley E.L., Fong S.F., et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Research 2005, 65:11429-11436.
245. Pei S., Minhajuddin M., Callahan K.P., Balys M., Ashton J.M., Neering S.J., et al. Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells. Journal of Biological Chemistry 2013, 288:33542-33558.
246. Pennington J.D., Jacobs K.M., Sun L., Bar-Sela G., Mishra M., Gius D. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Current Pharmaceutical Design 2007, 13:3368-3377.
247. Penta J.S., Johnson F.M., Wachsman J.T., Copeland W.C. Mitochondrial DNA in human malignancy. Mutation Research 2001, 488:119-133.
248. Pervaiz S., Taneja R., Ghaffari S. Oxidative stress regulation of stem and progenitor cells. Antioxidants and Redox Signaling 2009, 11:2777-2789.
249. Peskin A.V., Koen Y.M., Zbarsky I.B., Konstantinov A.A. Superoxide dismutase and glutathione peroxidase activities in tumors. FEBS Letters 1977, 78:41-45.
250. Piccoli C., D'Aprile A., Ripoli M., Scrima R., Lecce L., Boffoli D., et al. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochemical and Biophysical Research Communications 2007, 353:965-972.
251. Piccoli C., Ria R., Scrima R., Cela O., D'Aprile A., Boffoli D., et al. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. Journal of Biological Chemistry 2005, 280:26467-26476.
252. Pierce G.B., Speers W.C. Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Research 1988, 48:1996-2004.
253. Powis G., Mustacich D., Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radical Biology & Medicine 2000, 29:312-322.
254. Qin H., Yu T., Qing T., Liu Y., Zhao Y., Cai J., et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. Journal of Biological Chemistry 2007, 282:5842-5852.
255. Rafalski V.A., Mancini E., Brunet A. Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. Journal of Cell Science 2012, 125:5597-5608.
256. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked?. Free Radical Biology and Medicine 2010, 49:1603-1616.
257. Reya T. Regulation of hematopoietic stem cell self-renewal. Recent Progress in Hormone Research 2003, 58:283-295.
258. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
259. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biology & Medicine 2005, 38:1543-1552.
260. Ricci-Vitiani L., Pallini R., Biffoni M., Todaro M., Invernici G., Cenci T., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
261. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nature Reviews. Molecular Cell Biology 2008, 9:402-412.
262. Robles S.J., Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998, 16:1113-1123.
263. Rodriguez S., Wang L., Mumaw C., Srour E.F., Lo Celso C., Nakayama K., et al. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs. Blood 2011, 117:6509-6519.
264. Rusyn I., Asakura S., Pachkowski B., Bradford B.U., Denissenko M.F., Peters J.M., et al. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Research 2004, 64:1050-1057.
265. Rutter J., Reick M., Wu L.C., McKnight S.L. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 2001, 293:510-514.
266. Saeidnia S., Abdollahi M. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicology and Applied Pharmacology 2013, 273:442-455.
267. Sahu S.K., Oberley L.W., Stevens R.H., Riley E.F. Superoxide dismutase activity of Ehrlich ascites tumor cells. Journal of the National Cancer Institute 1977, 58:1125-1128.
268. Samper E., Fernandez P., Eguia R., Martin-Rivera L., Bernad A., Blasco M.A., et al. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood 2002, 99:2767-2775.
269. Saretzki G., Walter T., Atkinson S., Passos J.F., Bareth B., Keith W.N., et al. Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 2008, 26:455-464.
270. Sarsour E.H., Kumar M.G., Chaudhuri L., Kalen A.L., Goswami P.C. Redox control of the cell cycle in health and disease. Antioxidants & Redox Signaling 2009, 11:2985-3011.
271. Sato A., Okada M., Shibuya K., Watanabe E., Seino S., Narita Y., et al. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Research 2013, 12:119-131.
272. Sauer H., Wartenberg M. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxidants & Redox Signaling 2005, 7:1423-1434.
273. Sauvageau M., Sauvageau G. Polycomb group proteins: Multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010, 7:299-313.
274. Scarbrough P.M., Mapuskar K.A., Mattson D.M., Gius D., Watson W.H., Spitz D.R. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress. Free Radical Biology & Medicine 2012, 52:436-443.
275. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology & Medicine 2001, 30:1191-1212.
276. Schmelter M., Ateghang B., Helmig S., Wartenberg M., Sauer H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB Journal 2006, 20:1182-1184.
277. Schuringa J.J., Vellenga E. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Current Opinion in Hematology 2010, 17:294-299.
278. Seitz H.K., Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biological Chemistry 2006, 387:349-360.
279. Sell S. Stem cell handbook. Stem cells 2004, 1-18. Humana Press, Totowa, NJ. S. Sell (Ed.).
280. 2 homeostasis by hypoxia-inducible factor 1. Annual Review of Cell and Developmental Biology 1999, 15:551-578.
281. Semenza G.L. Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 2004, 19:176-182.
282. Semenza G.L. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene 2013, 32:4057-4063.
283. Serrano M., Blasco M.A. Putting the stress on senescence. Current Opinion in Cell Biology 2001, 13:748-753.
284. Shao L., Lou Y., Zhou D. Hematopoietic stem cell injury induced by ionizing radiation. Antioxidants & Redox Signaling 2014, 20:1447-1462.
285. Shao L., Sun Y., Zhang Z., Feng W., Gao Y., Cai Z., et al. Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood 2010, 115:4707-4714.
286. Shao L., Wang Y., Chang J., Luo Y., Meng A., Zhou D. Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury. Translational Cancer Research 2013, 2:397-411.
287. Shao L., Wu L., Zhou D. Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor kappaB kinase. Translational Cancer Research 2012, 1:100-108.
288. Sharpless N.E., DePinho R.A. The INK4A/ARF locus and its two gene products. Current Opinion in Genetics & Development 1999, 9:22-30.
289. Sherr C.J., Weber J.D. The ARF/p53 pathway. Current Opinion in Genetics & Development 2000, 10:94-99.
290. Shi X., Zhang Y., Zheng J., Pan J. Reactive oxygen species in cancer stem cells. Antioxidants & Redox Signaling 2012, 16:1215-1228.
291. Shiloh Y., Ziv Y. The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nature Reviews. Molecular Cell Biology 2013, 14:197-210.
292. Shima H., Takubo K., Tago N., Iwasaki H., Arai F., Takahashi T., et al. Acquisition of G(0) state by CD34-positive cord blood cells after bone marrow transplantation. Experimental Hematology 2010, 38:1231-1240.
293. Shouse S.S., Warren S.L., Whipple G.H.I.I. Aplasia of marrow and fatal intoxication in dogs produced by Roentgen radiation of all bones. Journal of Experimental Medicine 1931, 53:421-435.
294. Shyh-Chang N., Daley G.Q., Cantley L.C. Stem cell metabolism in tissue development and aging. Development 2013, 140:2535-2547.
295. Shyh-Chang N., Locasale J.W., Lyssiotis C.A., Zheng Y., Teo R.Y., Ratanasirintrawoot S., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339:222-226.
296. Sies H. Oxidative stress: From basic research to clinical application. American Journal of Medicine 1991, 91:31S-38S.
297. Simons A.L., Ahmad I.M., Mattson D.M., Dornfeld K.J., Spitz D.R. 2-Deoxy-d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Research 2007, 67:3364-3370.
298. Simons A.L., Parsons A.D., Foster K.A., Orcutt K.P., Fath M.A., Spitz D.R. Inhibition of glutathione and thioredoxin metabolism enhances sensitivity to perifosine in head and neck cancer cells. Journal of Oncology 2009, 2009:519563.
299. Simsek T., Kocabas F., Zheng J., Deberardinis R.J., Mahmoud A.I., Olson E.N., et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7:380-390.
300. Slane B.G., Aykin-Burns N., Smith B.J., Kalen A.L., Goswami P.C., Domann F.E., et al. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Research 2006, 66:7615-7620.
301. Slupianek A., Falinski R., Znojek P., Stoklosa T., Flis S., Doneddu V., et al. BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. Leukemia 2013, 27:629-634.
302. Sobhakumari A., Love-Homan L., Fletcher E.V., Martin S.M., Parsons A.D., Spitz D.R., et al. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism. PLoS One 2012, 7:e48175.
303. Spitz D.R., Azzam E.I., Li J.J., Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology. Cancer Metastasis Reviews 2004, 23:311-322.
304. 2-resistant cell lines. Do aldehydic by-products of lipid peroxidation contribute to oxidative stress?. Biochemical Journal 1990, 267:453-459.
305. Spitz D.R., Sim J.E., Ridnour L.A., Galoforo S.S., Lee Y.J. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?. Annals of the New York Academy of Sciences 2000, 899:349-362.
306. Spitz D.R., Sullivan S.J., Malcolm R.R., Roberts R.J. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radical Biology & Medicine 1991, 11:415-423.
307. Springer E.L. Comparative study of the cytoplasmic organelles of epithelial cell lines derived from human carcinomas and nonmalignant tissues. Cancer Research 1980, 40:803-817.
308. Stepanova L., Sorrentino B.P. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood 2005, 106:827-832.
309. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grunewald E., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. Journal of Experimental Medicine 2005, 201:1781-1791.
310. Suda T., Takubo K., Semenza G.L. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011, 9:298-310.
311. Sugimura R., He X.C., Venkatraman A., Arai F., Box A., Semerad C., et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 2012, 150:351-365.
312. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
313. Sun T.T., Green H. Differentiation of the epidermal keratinocyte in cell culture: Formation of the cornified envelope. Cell 1976, 9:511-521.
314. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
315. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
316. Takubo K., Goda N., Yamada W., Iriuchishima H., Ikeda E., Kubota Y., et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7:391-402.
317. Tamada M., Nagano O., Tateyama S., Ohmura M., Yae T., Ishimoto T., et al. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Research 2012, 72:1438-1448.
318. Tang D.G. Understanding cancer stem cell heterogeneity and plasticity. Cell Research 2012, 22:457-472.
319. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Research 2002, 62:1876-1883.
320. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
321. Till J.E., Mc C.E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research 1961, 14:213-222.
322. Tothova Z., Gilliland D.G. FoxO transcription factors and stem cell homeostasis: Insights from the hematopoietic system. Cell Stem Cell 2007, 1:140-152.
323. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
324. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?. Nature Reviews. Drug Discovery 2009, 8:579-591.
325. Trumpp A., Essers M., Wilson A. Awakening dormant haematopoietic stem cells. Nature Reviews. Immunology 2010, 10:201-209.
326. Tsai W.B., Chung Y.M., Takahashi Y., Xu Z., Hu M.C. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nature Cell Biology 2008, 10:460-467.
327. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., et al. Direct isolation of human central nervous system stem cells. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:14720-14725.
328. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxidants & Redox Signaling 2002, 4:405-414.
329. Unnisa Z., Clark J.P., Roychoudhury J., Thomas E., Tessarollo L., Copeland N.G., et al. Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood 2012, 120:4973-4981.
330. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F.C., et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.
331. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
332. Voet J.G., Voet D., Pratt C. Fundamentals of biochemistry: Electron transport and oxidative phosphorylation 1999, 492-525. John Wiley & Sons, Inc., New York.
333. Waegell W.O., Higley H.R., Kincade P.W., Dasch J.R. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta. Experimental Hematology 1994, 22:1051-1057.
334. Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K.E., Geber A., et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833.
335. Wang M., Kirk J.S., Venkataraman S., Domann F.E., Zhang H.J., Schafer F.Q., et al. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene 2005, 24:8154-8166.
336. Wang Y., Liu L., Pazhanisamy S.K., Li H., Meng A., Zhou D. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radical Biology & Medicine 2010, 48:348-356.
337. Wang Y., Liu L., Zhou D. Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiation Research 2011, 176:743-752.
338. Wang Y., Schulte B.A., LaRue A.C., Ogawa M., Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006, 107:358-366.
339. Wang Y., Schulte B.A., Zhou D. Hematopoietic stem cell senescence and long-term bone marrow injury. Cell Cycle 2006, 5:35-38.
340. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. Journal of Biological Chemistry 1995, 270:1230-1237.
341. Wang J., Sun Q., Morita Y., Jiang H., Gross A., Lechel A., et al. A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 2012, 148:1001-1014.
342. Warburg O. Beobachtungen über die Oxydationsprozesse im Seeigelei. Zeitschrift für Physiologische Chemie 1908, 57:1-6.
343. Wei S.J., Botero A., Hirota K., Bradbury C.M., Markovina S., Laszlo A., et al. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Research 2000, 60:6688-6695.
344. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annual Review of Cell and Developmental Biology 2001, 17:387-403.
345. Weyemi U., Redon C.E., Parekh P.R., Dupuy C., Bonner W.M. NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry 2013, 13:502-514.
346. Wickremasinghe R.G., Hoffbrand A.V. Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies. Blood 1999, 93:3587-3600.
347. Wilson A., Laurenti E., Oser G., van der Wath R.C., Blanco-Bose W., Jaworski M., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
348. Wilson A., Laurenti E., Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Current Opinion in Genetics & Development 2009, 19:461-468.
349. Winkler I.G., Barbier V., Wadley R., Zannettino A.C., Williams S., Levesque J.P. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: Serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood 2010, 116:375-385.
350. Wong J.L., Creton R., Wessel G.M. The oxidative burst at fertilization is dependent upon activation of the dual oxidase Udx1. Developmental Cell 2004, 7:801-814.
351. Wong J.L., Wessel G.M. Reactive oxygen species and Udx1 during early sea urchin development. Developmental Biology 2005, 288:317-333.
352. Xiao Q., Luo Z., Pepe A.E., Margariti A., Zeng L., Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. American Journal of Physiology. Cell Physiology 2009, 296:C711-C723.
353. Yahata T., Takanashi T., Muguruma Y., Ibrahim A.A., Matsuzawa H., Uno T., et al. Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 2011, 118:2941-2950.
354. Yalcin S., Zhang X., Luciano J.P., Mungamuri S.K., Marinkovic D., Vercherat C., et al. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. Journal of Biological Chemistry 2008, 283:25692-25705.
355. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. New England Journal of Medicine 2005, 352:1413-1424.
356. Yamaguchi M., Kashiwakura I. Role of reactive oxygen species in the radiation response of human hematopoietic stem/progenitor cells. PLoS One 2013, 8:e70503.
357. Yamazaki S., Ema H., Karlsson G., Yamaguchi T., Miyoshi H., Shioda S., et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 2011, 147:1146-1158.
358. Yankovskaya V., Horsefield R., Tornroth S., Luna-Chavez C., Miyoshi H., Leger C., et al. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 2003, 299:700-704.
359. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
360. Yoshihara H., Arai F., Hosokawa K., Hagiwara T., Takubo K., Nakamura Y., et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007, 1:685-697.
361. Yu H., Shen H., Yuan Y., XuFeng R., Hu X., Garrison S.P., et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood 2010, 115:3472-3480.
362. Zeng X. Human embryonic stem cells: Mechanisms to escape replicative senescence?. Stem Cell Reviews 2007, 3:270-279.
363. Zhang J., Grindley J.C., Yin T., Jayasinghe S., He X.C., Ross J.T., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006, 441:518-522.
364. Zhang H., Mi J.Q., Fang H., Wang Z., Wang C., Wu L., et al. Preferential eradication of acute myelogenous leukemia stem cells by fenretinide. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:5606-5611.
365. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.G., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
366. Zhang X., Yalcin S., Lee D.F., Yeh T.Y., Lee S.M., Su J., et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nature Cell Biology 2011, 13:1092-1099.
367. Zhang H., Zhai Z., Wang Y., Zhang J., Wu H., Li C., et al. Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radical Biology & Medicine 2013, 54:40-50.
368. Zhou L., Opalinska J., Verma A. p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle 2007, 6:534-537.
369. Zhou F., Shen Q., Claret F.X. Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia. Journal of Leukocyte Biology 2013, 94:423-429.
370. Zhu S., Li W., Zhou H., Wei W., Ambasudhan R., Lin T., et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010, 7:651-655.